Evaluating the Efficacy and Safety of Dehypotin® in the Patients With Type 2 Diabetes Mellitus or Cardiovascular Disease
Status:
Terminated
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the Efficacy and Safety of Dehypotin® in the
Patients with Type 2 Diabetes Mellitus or Cardiovascular Disease. Eligible patients will be
randomly assigned to 1 of 2 arms, either Dehypotin® or placebo, and will receive the diet
advisement throughout the study.